These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11959860)

  • 21. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
    Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
    J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
    Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
    Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning and characterization of a TAR-binding nuclear factor from T cells.
    Reddy TR; Suhasini M; Rappaport J; Looney DJ; Kraus G; Wong-Staal F
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):663-9. PubMed ID: 7576925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
    J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
    Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
    Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J; Frankel AD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transactivation of heterologous promoters by HIV-1 tat.
    Han P; Brown R; Barsoum J
    Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
    Xie B; Wainberg MA; Frankel AD
    J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New human gene encoding a positive modulator of HIV Tat-mediated transactivation.
    Shibuya H; Irie K; Ninomiya-Tsuji J; Goebl M; Taniguchi T; Matsumoto K
    Nature; 1992 Jun; 357(6380):700-2. PubMed ID: 1377363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
    Gatignol A; Duarte M; Daviet L; Chang YN; Jeang KT
    Gene Expr; 1996; 5(4-5):217-28. PubMed ID: 8723388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat.
    Zhou Q; Sharp PA
    Science; 1996 Oct; 274(5287):605-10. PubMed ID: 8849451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.
    Garber ME; Wei P; KewalRamani VN; Mayall TP; Herrmann CH; Rice AP; Littman DR; Jones KA
    Genes Dev; 1998 Nov; 12(22):3512-27. PubMed ID: 9832504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
    Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA.
    Hart CE; Saltrelli MJ; Galphin JC; Schochetman G
    J Virol; 1995 Oct; 69(10):6593-9. PubMed ID: 7666565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression.
    Kim YS; Panganiban AT
    J Virol; 1993 Jul; 67(7):3739-47. PubMed ID: 8510203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors.
    Ambrosino C; Ruocco MR; Chen X; Mallardo M; Baudi F; Trematerra S; Quinto I; Venuta S; Scala G
    J Biol Chem; 1997 Jun; 272(23):14883-92. PubMed ID: 9169458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B--a review.
    Taylor JP; Khalili K
    Adv Neuroimmunol; 1994; 4(3):291-303. PubMed ID: 7874398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.